- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 4/12 - Peptides having up to 20 amino acids in an undefined or only partially defined sequenceDerivatives thereof from animalsPeptides having up to 20 amino acids in an undefined or only partially defined sequenceDerivatives thereof from humans
Patent holdings for IPC class C07K 4/12
Total number of patents in this class: 182
10-year publication summary
|
21
|
11
|
12
|
7
|
7
|
11
|
6
|
5
|
11
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Immunocore Limited | 247 |
13 |
| Adaptimmune Limited | 139 |
11 |
| The Regents of the University of California | 20924 |
5 |
| Oncotherapy Science, Inc. | 236 |
5 |
| Centre National de La Recherche Scientifique | 11122 |
4 |
| Dana-Farber Cancer Institute, Inc. | 2677 |
4 |
| The United States of America as represented by the Department of Veterans Affairs | 298 |
4 |
| The Board of Regents of the University of Texas System | 2312 |
4 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3324 |
3 |
| NEON Therapeutics, Inc. | 11 |
3 |
| University of Oregon | 210 |
3 |
| BioNTech US Inc. | 88 |
3 |
| NEOGAP Therapeutics AB | 29 |
3 |
| Etablissement Francais du Sang | 179 |
2 |
| Immatics Biotechnologies GmbH | 1127 |
2 |
| Institut Curie | 625 |
2 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 3313 |
2 |
| Institute of Microbiology, Chinese Academy of Sciences | 141 |
2 |
| Lipotrue, S.L. | 172 |
2 |
| Mackay Memorial Hospital | 39 |
2 |
| Other owners | 103 |